{
  "docId": "019de50e-d292-716f-9ce2-d72fb83a57c0",
  "docSlug": "bede1f03edbb16951b81551a4f6eebab",
  "documentTitle": "Theranos | Investor Conference Presentation Deck | 88 slides",
  "authorId": "theranos",
  "authorName": "Theranos",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2016-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 52,
  "pageCount": 88,
  "prevPage": 51,
  "nextPage": 53,
  "slideType": "appendix_methodology",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "References CLSI EP05-A3 standard for precision performance testing.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de50e-d292-716f-9ce2-d72fb83a57c0/52",
  "deckHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0",
  "deckJsonHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0.json",
  "deckAnchorHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0#slide-52",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "This technology has not been cleared or approved by the FDA and is not for sale in the United States.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fecf4829-cc50-4141-a032-3a25b38b1a21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.94,
        "x": 0.03,
        "y": 0.23
      },
      "kind": "table",
      "text": "Sample type and matrix: Quality control material (R&D Systems StatusFlow); Control levels: CD4 Low (all other analytes normal), CD4 Normal (all other analytes normal); Study Design: 3 miniLabs x 5 Days x 5 Tests per day (CLSI EP05-A3); Analysis: Analysis of variance to determine repeatability, within-lab variability, and reproducibility",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff8d802f-1b4d-4aa8-aa1c-009b2f6160e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "T Cell, B Cell, NK Cells (TBNK, Lymphocyte Subset): Precision Study Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "935ebe3e-86b9-4cb2-97fd-613324a5435d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "analytical-method",
      "slug": null,
      "matchId": "1d8182af-3aaa-4e98-b5ce-34b44d110c19",
      "evidence": "References CLSI EP05-A3 standard for precision study design.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 67,
      "from": 52,
      "beatId": "8558673a-c195-4497-afc2-021a5425cec9",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Solution",
      "beatSlug": null,
      "evidence": "The document presents the solution and its benefits",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}